Chronic Myelomonocytic Leukemia
What's New
Last Posted: Aug 14, 2024
- Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow.
Do Hwan Kim, et al. Clinical lymphoma, myeloma & leukemia 2024 0 - ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Clifford M Csizmar, et al. Haematologica 2024 0 - Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Seon Young Kim, et al. Annals of diagnostic pathology 2024 0 152317 - A novel 3q interstitial deletion including GATA2 and ZNF148: A case report.
Elizabeth Martin, et al. American journal of medical genetics. Part A 2024 0 e63621 - NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy.
Laura Hurtado-Navarro, et al. Cell reports. Medicine 2023 0 (12) 101329 - Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms.
Maria Teresa Bochicchio, et al. International journal of molecular sciences 2023 0 (22) - Impact of BRAF mutation on aggressiveness and outcomes in adult clonal histiocytosis.
Jerome Razanamahery, et al. Frontiers in immunology 2023 0 1260193 - Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Alex Bataller, et al. American journal of hematology 2023 0 - Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.
Xavier Calvo, et al. International journal of laboratory hematology 2023 0 - DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.
Palomo Laura, et al. Epigenetics 2017 0 (1) 8-18
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: